Ollie's had a mediocre quarter despite outperforming EPS and Same Store Sales estimates, as revenue missed and full-year guidance fell short. The company's stock fell 4.1% and future performance may be influenced by its valuation, business qualities, and recent results.
The market seems less excited about Ollie's Bargain Outlet Holdings than before, which could present an investment opportunity. The recent improvement in returns could suggest a positive shift within the business.
CEO notes strong closeout deal flow as consumers look to save on branded items, creating more opportunities. FY24 revenue estimated at $2.097B to $2.104B with an EPS of $2.77 to $2.83, outpacing consensus estimate.
CEO John Swygert expresses positive sentiments on Ms. Baglivo's appointment, stating that they're seeking to benefit from her extensive marketing and advertising experience and overall business acumen for executing their growth strategies and building the Ollie's brand.
Despite market incorporating OLLI's future growth, the stock appears steep due to high P/E ratio. Potential investors might find the current price prohibitive, while shareholders may consider selling, assuming stock should trade below current price due to high industry P/E ratio.
Q2 results impacted individual stocks with Ollie's, Nordstrom, Five Below, Dillard's, and Macy's witnessing a drop. Ollie’s improved outlook could lift its share price, while Nordstrom and Dillard's showed resilience. Macy's and Five Below's performance fell short, causing investor worry due to Macy's weaker annual guidance.
Gapping up $惠普(HPQ.US)$+2.6% (JPMorgan upgraded computer builder to overweight from neutral, saying it expects the PC industry to see upward revisions for the second half of this year. JPMorgan also downgraded Dell to neutral from overweight, citing its preference for HP's expected recovery, as Dell's PC segment will likely be offset by other factors. ) $Prometheus Biosciences(RXDX.US)$+69% (The company will be acquired by$默沙東(MRK.US)$for $10.8...
Ollie's Bargain Outlet股票討論區
2024Q1營收增長12.9%,營業利潤增長1.2倍,淨利潤增長1.5倍。
目前市盈率42,市盈率TTM已經降到了35.6,如果全年淨利潤達到2021年的2.4億,相當於1季度淨利潤的8倍,那麼市盈率將降到18,如果達到1季度的6倍,對應市盈率爲24,看起來似乎還不錯,不過僅有一個月的暴增數據是不夠的,可以多等幾份財報再做判斷。
專欄Today's Pre-Market Stock Movers: HPQ, GOOGL, WOLF, RXDX and More
$惠普(HPQ.US)$ +2.6% (JPMorgan upgraded computer builder to overweight from neutral, saying it expects the PC industry to see upward revisions for the second half of this year. JPMorgan also downgraded Dell to neutral from overweight, citing its preference for HP's expected recovery, as Dell's PC segment will likely be offset by other factors. )
$Prometheus Biosciences(RXDX.US)$ +69% (The company will be acquired by $默沙東(MRK.US)$ for $10.8...
專欄Top upgrades and downgrades on 6/27: ETSY, CHWY, BBBY, GTLB and more
• $汽車地帶(AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy(CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision(EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $費森尤斯醫療(FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab(GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...
暫無評論